Manchester United to Conduct Medical for Tottenham’s Sergio Reguilon Amid Chelsea’s Loan Fee Impasse

Manchester United Set to Secure Loan Deal for Tottenham’s Sergio Reguilon

In a significant move, Tottenham’s left-back, Sergio Reguilon, is poised to join Manchester United on a loan basis, following a breakdown in negotiations over Marc Cucurella’s potential transfer to Chelsea. Reguilon’s transfer is now imminent as he prepares to undergo a medical examination with the Red Devils.

The impasse arose when Chelsea demanded a £7 million loan fee for Marc Cucurella, leading to the collapse of the deal. Cucurella even participated in a match against Wimbledon on Wednesday night, but the financial terms could not be met.

Sergio Reguilon’s future with Tottenham appears uncertain under the management of Ange Postecoglou. He hasn’t been featured in the team’s lineup this season, suggesting a possible lack of opportunities. Reguilon’s past season was spent on loan at Atletico Madrid, where he gained valuable experience.

Manchester United’s pursuit of Reguilon stems from their current situation with injured players. Both Luke Shaw and Tyrell Malacia are sidelined due to injuries, leaving the club short of left-back options. Shaw’s absence, in particular, might extend to approximately two months due to a muscle injury.

Having initially joined Tottenham from Real Madrid in 2020, Sergio Reguilon has made a notable 67 appearances for the club based in North London. This impending loan transfer to Manchester United is a strategic move, driven by the desire to reinforce the team’s left-back position while addressing the current injury concerns.

United’s manager, Erik ten Hag, is actively seeking a solution to the left-back predicament brought about by Shaw’s injury. With the imminent arrival of Reguilon, Manchester United aims to bolster their squad for the upcoming challenges of the season.

Stay updated with the latest transfer news on the penultimate day of the summer window through Mail Sport’s live coverage.

Leave a Reply